This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

MYOCARDITIS
Loading...

Kishimoto, C


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Kishimoto C, Abelmann WH. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice. Circulation. 1989 Jun;79(6):1300-8. doi: 10.1161/01.cir.79.6.1300. PubMed PMID: 2541943.
39.918
Kishimoto C, Kuribayashi K, Masuda T, Tomioka N, Kawai C. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation. 1985 Jun;71(6):1247-54. doi: 10.1161/01.cir.71.6.1247. PubMed PMID: 2986878.
39.918
Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation. 1994 Jun;89(6):2836-42. doi: 10.1161/01.cir.89.6.2836. PubMed PMID: 8205699.
39.918
Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Circulation. 1995 Sep 15;92(6):1604-11. doi: 10.1161/01.cir.92.6.1604. PubMed PMID: 7664447.
39.918
Kishimoto C, Thorp KA, Abelmann WH. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. Circulation. 1990 Sep;82(3):982-9. doi: 10.1161/01.cir.82.3.982. PubMed PMID: 2168299.
39.918
Kishimoto C, Takada H, Hiraoka Y. Intravenous IgG: supertherapy for myocarditis and acute dilated cardiomyopathy. Circulation. 1999 Feb 23;99(7):975. No abstract available. PubMed PMID: 10027823.
39.918
Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation. 1988 Mar;77(3):645-53. doi: 10.1161/01.cir.77.3.645. PubMed PMID: 2830046.
39.918
Hiraoka Y, Kishimoto C, Takada H, Suzaki N, Shiraki K. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice. Eur Heart J. 1995 Dec;16(12):1900-6. doi: 10.1093/oxfordjournals.eurheartj.a060845. PubMed PMID: 8682024.
35.855
Kishimoto C, Takamatsu N, Kawamata H, Shinohara H, Ochiai H. Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change. J Am Coll Cardiol. 2000 Nov 15;36(6):1979-84. doi: 10.1016/s0735-1097(00)00978-5. PubMed PMID: 11092674.
27.203
Kishimoto C, Hung GL, Ishibashi M, Khaw BA, Kolodny GM, Abelmann WH, Yasuda T. Natural evolution of cardiac function, cardiac pathology and antimyosin scan in a murine myocarditis model. J Am Coll Cardiol. 1991 Mar 1;17(3):821-7. doi: 10.1016/s0735-1097(10)80203-7. PubMed PMID: 1847155.
27.203
Kishimoto C, Crumpacker CS, Abelmann WH. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. J Am Coll Cardiol. 1988 Nov;12(5):1334-41. doi: 10.1016/0735-1097(88)92618-6. PubMed PMID: 2844874.
27.203
Kishimoto C, Matsumori A, Ohmae M, Tomioka N, Kawai C. Electrocardiographic findings in experimental myocarditis in DBA/2 mice: complete atrioventricular block in the acute stage, low voltage of the QRS complex in the subacute stage and arrhythmias in the chronic stage. J Am Coll Cardiol. 1984 Jun;3(6):1461-8. doi: 10.1016/s0735-1097(84)80285-5. PubMed PMID: 6325521.
27.203
Tomioka N, Kishimoto C, Matsumori A, Kawai C. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol. 1986 Apr;7(4):868-72. doi: 10.1016/s0735-1097(86)80349-7. PubMed PMID: 3007597.
27.203
Kishimoto C, Kurnick JT, Fallon JT, Crumpacker CS, Abelmann WH. Characteristics of lymphocytes cultured from murine viral myocarditis specimens: a preliminary and technical report. J Am Coll Cardiol. 1989 Sep;14(3):799-802. doi: 10.1016/0735-1097(89)90128-9. PubMed PMID: 2768726.
27.203
Hiraoka Y, Kishimoto C, Takada H, Nakamura M, Kurokawa M, Ochiai H, Shiraki K. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol. 1996 Nov 15;28(6):1610-5. doi: 10.1016/s0735-1097(96)00372-5. PubMed PMID: 8917278.
27.203
Kishimoto C, Abelmann WH. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Circ Res. 1990 Sep;67(3):589-98. doi: 10.1161/01.res.67.3.589. PubMed PMID: 1697791.
23.213
Shioji K, Kishimoto C, Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ Res. 2001 Sep 14;89(6):540-6. doi: 10.1161/hh1801.096263. PubMed PMID: 11557742.
23.213
Kishimoto C, Kuribayashi K, Fukuma K, Masuda T, Tomioka N, Abelmann WH, Kawai C. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis. Circ Res. 1987 Nov;61(5):715-25. doi: 10.1161/01.res.61.5.715. PubMed PMID: 2889539.
23.213
Schnitt SJ, Stillman IE, Owings DV, Kishimoto C, Dvorak HF, Abelmann WH. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. Circ Res. 1993 Apr;72(4):914-20. doi: 10.1161/01.res.72.4.914. PubMed PMID: 7680288.
23.213
Kishimoto C, Abelmann WH. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage. Circ Res. 1989 Oct;65(4):934-45. doi: 10.1161/01.res.65.4.934. PubMed PMID: 2551533.
23.213
Kishimoto C, Takada H, Hiraoka Y, Shiraki K. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse. Cardiovasc Res. 1995 Jan;29(1):80-4. PubMed PMID: 7895243.
13.081
Tomioka N, Kishimoto C, Matsumori A, Kawai C. Mural thrombus in experimental viral myocarditis in mice: relation between thrombosis and congestive heart failure. Cardiovasc Res. 1986 Sep;20(9):665-71. doi: 10.1093/cvr/20.9.665. PubMed PMID: 3791356.
13.081
Kishimoto C, Crumpacker CS, Abelmann WH. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D. Cardiovasc Res. 1988 Oct;22(10):732-8. doi: 10.1093/cvr/22.10.732. PubMed PMID: 2855719.
13.081
Kishimoto C, Kuribayashi K, Masuda T, Tomioka N, Kawai C. Animal model of silent myocarditis in athymic mice. Cardiovasc Res. 1986 Oct;20(10):768-73. doi: 10.1093/cvr/20.10.768. PubMed PMID: 3024835.
13.081
Kishimoto C, Takada H, Kuroki Y, Matsushita I, Hiraoka Y, Kurokawa M, Ochiai H, Sasayama S. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. Cardiovasc Res. 1993 Feb;27(2):243-8. doi: 10.1093/cvr/27.2.243. PubMed PMID: 8386064.
13.081
Hiraoka Y, Kishimoto C, Kurokawa M, Ochiai H, Sasayama S. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice. Cardiovasc Res. 1992 Oct;26(10):956-61. doi: 10.1093/cvr/26.10.956. PubMed PMID: 1336713.
13.081
Hiraoka Y, Kishimoto C, Takada H, Kurokawa M, Ochiai H, Shiraki K, Sasayama S. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res. 1993 Jun;27(6):957-61. doi: 10.1093/cvr/27.6.957. PubMed PMID: 8221785.
13.081
Kishimoto C, Kuroki Y, Kurokawa M, Ohiai H. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis. Basic Res Cardiol. 1997 Dec;92(6):402-9. doi: 10.1007/BF00796214. PubMed PMID: 9464864.
12.416
Kishimoto C, Hiraoka Y, Takada H. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice. Basic Res Cardiol. 2001 Sep;96(5):439-45. doi: 10.1007/s003950170025. PubMed PMID: 11605990.
12.416
Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Heart. 2005 Sep;91(9):1203-8. doi: 10.1136/hrt.2004.046292. Epub 2005 Mar 17. PubMed PMID: 15774612; PubMed Central PMCID: PMC1769084.
7.365
Sasayama S, Matsumori A, Matoba Y, Matsui S, Yamada T, Shioi T, Sato Y, Doyama K, Kishimoto C. Immunomodulation: a new horizon for medical treatment of heart failure. J Card Fail. 1996 Dec;2(4 Suppl):S287-94. doi: 10.1016/s1071-9164(96)80089-3. PubMed PMID: 8951591.
6.592
Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H. Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. J Virol. 2001 Feb;75(3):1294-300. doi: 10.1128/JVI.75.3.1294-1300.2001. PubMed PMID: 11152502; PubMed Central PMCID: PMC114035.
6.549
Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H. Role of MIP-2 in coxsackievirus B3 myocarditis. J Mol Cell Cardiol. 2000 Apr;32(4):631-8. doi: 10.1006/jmcc.2000.1102. PubMed PMID: 10756119.
5.763
Kishimoto C, Takada H, Hiraoka Y, Shinohara H, Kitazawa M. Protection against murine coxsackievirus B3 myocarditis by T cell vaccination. J Mol Cell Cardiol. 2000 Dec;32(12):2269-77. doi: 10.1006/jmcc.2000.1253. PubMed PMID: 11113002.
5.763
Hiraoka Y, Kishimoto C, Takada H, Suzaki N, Shiraki K. Colony-stimulating factors and coxackievirus B3 myocarditis in mice: macrophage colony-stimulating factor suppresses acute myocarditis with increasing interferon-alpha. Am Heart J. 1995 Dec;130(6):1259-64. doi: 10.1016/0002-8703(95)90152-3. PubMed PMID: 7484779.
5.099
Kishimoto C, Takada H, Kawamata H, Umatake M, Ochiai H. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines. J Pharmacol Exp Ther. 2001 Nov;299(2):645-51. PubMed PMID: 11602677.
4.402
Hiraoka Y, Kishimoto C, Kurokawa M, Ochiai H, Sasayama S. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. J Pharmacol Exp Ther. 1992 Mar;260(3):1386-91. PubMed PMID: 1372051.
4.402
Shioji K, Kishimoto C, Nakamura H, Toyokuni S, Nakayama Y, Yodoi J, Sasayama S. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett. 2000 Apr 21;472(1):109-13. doi: 10.1016/s0014-5793(00)01446-0. PubMed PMID: 10781815.
3.864
Kishimoto C, Matsumori A, Tomioka N, Sakurai T, Kawai C. [Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies]. J Cardiogr Suppl. 1986;(9):19-25. Japanese. PubMed PMID: 3020133.
3.815
Tomioka N, Kishimoto C, Matsumori A, Kawai T, Tamaki S. [A case of acute myocarditis immunologically studied with monoclonal antibody]. J Cardiol Suppl. 1989;22:25-6. No abstract available. Japanese. PubMed PMID: 2640863.
3.815
Kishimoto C, Kitazawa M, Takada H. Interstitial fibrin-fibronectin deposition with T cell infiltrates precedes fibrosis in murine viral myocarditis. Int J Exp Pathol. 1998 Dec;79(6):417-23. doi: 10.1046/j.1365-2613.1998.00079.x. PubMed PMID: 10319022; PubMed Central PMCID: PMC3220375.
2.793
Kishimoto C, Hiraoka Y. Clinical and experimental studies in myocarditis. Curr Opin Cardiol. 1994 May;9(3):349-56. doi: 10.1097/00001573-199405000-00014. PubMed PMID: 8049593.
2.108
Takada H, Kishimoto C, Kuroki Y, Matsushita I, Hiraoka Y, Kurokawa M, Ochiai H, Sasayama S. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. Heart Vessels. 1993;8(2):59-66. doi: 10.1007/BF01744384. PubMed PMID: 8390975.
1.814
Kishimoto C, Takada H, Hiraoka Y, Kurokawa M, Ochiai H. Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditis. Heart Vessels. 1997;12(2):67-73. doi: 10.1007/BF02820869. PubMed PMID: 9403310.
1.814
Kishimoto C, Hiraoka Y, Takada H, Kurokawa M, Ochiai H. Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice. Heart Vessels. 1997;12(5):221-8. doi: 10.1007/BF02766787. PubMed PMID: 9846807.
1.814
Kishimoto C, Ochiai H, Sasayama S. Intracardiac thrombus in murine Coxsackievirus B3 myocarditis. Heart Vessels. 1992;7(2):76-81. doi: 10.1007/BF01744452. PubMed PMID: 1328146.
1.814
Kishimoto C, Tomioka N, Kawai C. Clinical findings in acute viral myocarditis. With special attention to experimental and immunological evidence. Herz. 1985 Feb;10(1):15-20. PubMed PMID: 2984098.
1.74
Shioji K, Kishimoto C, Nakayama Y, Sasayama S. Strain difference in rats with experimental giant cell myocarditis. Jpn Circ J. 2000 Apr;64(4):283-6. doi: 10.1253/jcj.64.283. PubMed PMID: 10783051.
Kishimoto C, Tamaki S, Matsumori A, Tomioka N, Kawai C. The protection of coenzyme Q10 against experimental viral myocarditis in mice. Jpn Circ J. 1984 Dec;48(12):1358-61. doi: 10.1253/jcj.48.1358. PubMed PMID: 6096581.
Takada H, Kishimoto C, Hiraoka Y, Kurokawa M, Shiraki K, Sasayama S. Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis. Am J Physiol. 1997 Jan;272(1 Pt 2):H211-9. doi: 10.1152/ajpheart.1997.272.1.H211. PubMed PMID: 9038940.
Nakayama Y, Kishimoto C, Shioji K, Sasayama S. Significance of pericardial cytokines in giant cell myocarditis in rats--pathological comparison to viral myocarditis in mice. Jpn Circ J. 2000 Dec;64(12):977-81. doi: 10.1253/jcj.64.977. PubMed PMID: 11194294.
Matsumori A, Kishimoto C, Kawai C, Sawada S. Right ventricular aneurysms complicating encephalomyocarditis virus myocarditis in mice. Jpn Circ J. 1983 Nov;47(11):1322-4. doi: 10.1253/jcj.47.1322. PubMed PMID: 6315987.
Kishimoto C, Spry CJ, Tai PC, Tomioka N, Kawai C. The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparation. Jpn Circ J. 1986 Dec;50(12):1264-7. doi: 10.1253/jcj.50.1264. PubMed PMID: 3029448.
Miyamoto M, Kishimoto C, Shioji K, Nakamura H, Toyokuni S, Nakayama Y, Kita M, Yodoi J, Sasayama S. Difference in thioredoxin expression in viral myocarditis in inbred strains of mice. Jpn Circ J. 2001 Jun;65(6):561-4. doi: 10.1253/jcj.65.561. PubMed PMID: 11407741.
Kishimoto C, Tomioka N, Sakurai T, Kawai C, Araya S, Iwamoto S, Aoki K. [Immunologic backgrounds of patients with cardiomyopathy and myocarditis]. Kokyu To Junkan. 1986 Aug;34(8):871-3. No abstract available. Japanese. PubMed PMID: 3786954.
Kishimoto C, Tomioka N, Tamaki S, Kawai C. A case of myocarditis with immunological identification of myocardial and peripheral lymphocyte subsets. Jpn Circ J. 1988 Jan;52(1):94-8. doi: 10.1253/jcj.52.94. PubMed PMID: 3283389.
Kishimoto C, Matsumori A, Kawai C. Electrocardiographic findings in experimental murine myocarditis--arrhythmias in the chronic stage. Jpn Circ J. 1983 Nov;47(11):1317-21. doi: 10.1253/jcj.47.1317. PubMed PMID: 6315986.
Tomioka N, Kishimoto C, Matsumori A, Kawai C. Mural thrombi in mice with acute viral myocarditis. Jpn Circ J. 1985 Dec;49(12):1277-9. doi: 10.1253/jcj.49.1277. PubMed PMID: 3007795.
Kishimoto C, Ochiai H, Sasayama S. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice. Jpn Circ J. 1991 Nov;55(11):1144-8. doi: 10.1253/jcj.55.1144. PubMed PMID: 1721094.
Kishimoto C, Kitazawa M, Hiraoka Y, Takada H. Extracellular matrix remodeling in coxsackievirus B3 myocarditis. Clin Immunol Immunopathol. 1997 Oct;85(1):47-55. doi: 10.1006/clin.1997.4418. PubMed PMID: 9325069.

Data Sources

PubMed
NCBI
SemanticScholar
Web of Science
Human Phenotype ontology
KEGG
IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

E-mail

Phones

+34 968885229
+34 968885239
+34 968885249

Advanced Charts